A pioneering multi-modal framework with TCR-peptide-HLA sequence and structure features incorporating an attention mechanism designed to accurately identify tumor antigens with immunogenic properties, which presents a brand-new and promising approach for cancer immunotherapies that target tumor antigens.
The ImmunoFoundation Model (IFM), a multimodal deep learning system that integrates not only peptide sequences, 3D molecular structures, and biochemical properties but also TCR-MHC-peptide to achieve superior immunogenicity prediction and enable peptide optimization for therapeutic applications is developed.
Smita Krishnaswamy, J. Rocha, Hiren Madhu et al.· Journal of Immunology· 0 citations
This work is the first to use a multi-modal foundation model for neoantigen vaccines, overcoming the tumor-type-specific constraints of conventional approaches and facilitating joint modelling of immunogenicity and clinical efficacy, thereby offering an AI decision engine for precision cancer vaccine design that is app...
Gang Liu, Jia Wang, Jia Zhu· Global Health Care· 2 citations
The current role of AI is summarized across the peptide cancer vaccine development pipeline, from neoantigen discovery and epitope prioritization to prediction of peptide–HLA binding, antigen presentation, and T-cell receptor recognition, and the application of modern computational frameworks.
P. Brlek, J. Kolić, L. Bulić et al.· Frontiers in Genetics· 0 citations
AAMFM, an Antigen-specific Antibody Multimodal Foundation Model that learns unified representations of antibody sequences and structures conditioned on antigen context, achieves state-of-the-art performance in functional antibody design, revealing its potential for antigen-specific antibody engineering.
Xiaoliang Shi, Zichen Wang, Runze Ma et al.· arXiv.org· 0 citations
Breast cancer, particularly hormone receptor-positive (HR+) and triple-negative (TNBC) subtypes, is often immunologically "cold," limiting immunotherapy efficacy. Neoantigen-based vaccines hold promise but face challenges from inaccurate identification and overreliance on HLA binding affinity, which poorly captures tru...
Van-The Le, Juan Peter Timothy Yuune, Jiun-I Lai et al.· Biochemical and Biophysical...· 0 citations
Evaluation across multiple settings indicates that TCR-IFNet achieves competitive performance compared with existing methods, with higher AUPRC observed on both antigen-specific and healthy-sourced datasets, as well as improved results on independent test sets.
Wen-Yu Xi, Ru-Heng Wang, Xiu-Cai Ye et al.· International Journal of Bio...· 0 citations
Related blog posts
Microsoft Research Blog· microsoft.comNov 16, 2026
AI coding agents are increasingly help developers fix bugs and build features largely on their own, but every interaction with their models consumes tokens. In each session, an agent sends instructions, tool descriptions, and session history to its model. Most efforts to reduce this cost focus on individual tasks. Yet developers return to the same […] The post TokenEconomizer: Learning from Experience to Make AI Coding Agents More Efficient appeared first on Microsoft Research.
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A machine-learning approach called CheMeleon provides a practical way to develop new drugs or other molecules with much less detailed, expensive experimentation.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.